tiprankstipranks
Advertisement
Advertisement

Venture Life tightens share base with latest buyback tranche

Story Highlights
  • Venture Life repurchased 88,684 shares under its buyback plan, holding them in treasury.
  • The transaction leaves 122,957,864 voting rights, clarifying stakes and disclosure thresholds.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life tightens share base with latest buyback tranche

Claim 55% Off TipRanks

Venture Life ( (GB:VLG) ) has provided an update.

Venture Life Group has repurchased 88,684 ordinary shares at a volume-weighted average price of 67.93 pence under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 5,902,281 are held in treasury, resulting in 122,957,864 voting rights, a figure shareholders can use to assess disclosure obligations under FCA transparency rules.

The buyback marginally reduces the free float and may enhance earnings per share over time, signalling management’s confidence in the company’s valuation and capital position. The updated share and voting-rights structure also provides clarity for investors and regulators, supporting orderly trading and compliance with UK market disclosure requirements.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is an international consumer self-care company operating in the global consumer healthcare sector and focused on proactive healthy longevity. Headquartered in the UK, it develops and commercialises products such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management, and the Health & Her range for hormonal support, distributing through pharmacies, health and beauty stores, grocery multiples, e-commerce and international partners.

Average Trading Volume: 333,709

Technical Sentiment Signal: Buy

Current Market Cap: £83.06M

See more data about VLG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1